Experts shared diagnosis and management strategies for chronic pruritus at the Dermatology Days of Paris 2024 conference.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting ...

Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.

Winter itch is a type of dermatitis - also known as pruritus hiemalis - that mostly occurs when the outdoor temperature drops ...

ASN-008 is under clinical development by Formation Bio and currently in Phase II for Pruritus. According to GlobalData, Phase II drugs for Pruritus have a 50% phase transition success rate (PTSR) ...

Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have been given a consensus rating of “Buy” by the eleven analysts that are presently covering the firm, Marketbeat.com reports.

Biotech M&A is heating up, and Mirum Pharmaceuticals stands out. Discover why analysts predict a 50% upside and long-term ...

While a mild itch is usually no biggie, a persistent itch could be pruritus ani (aka the medical name for anal itching). It ...

Jasper Therapeutics, Inc. (NASDAQ:JSPR) reported preliminary data from the ongoing BEACON Phase 1b/2a study of subcutaneous ...

Peter Percy, from North Shields, admitted failing to provide a suitable living environment for four Shar Pei type dogs, three ...